Search Within

Harry W Herr

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (75)
  2. Meeting Abstract (19)
  3. Book Section (2)
  4. Conference Paper (2)
  5. Guidelines (2)
  6. Book Whole (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Review (1)
Groups
  1. Department of Medicine (104)
  2. Genitourinary Oncology Service (104)
  3. Solid Tumor Oncology Division (104)
  4. Surgery (104)
  5. Urology (104)
  6. Survivorship Research (36)

More Groups

People
  1. Dean Bajorin (73)
  2. Howard Scher (34)
  3. Sherri Donat (34)
  4. Bernard Bochner (33)
  5. Guido Dalbagni (32)
  6. Pramod Sogani (23)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (4)
  5. 2021 (2)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Journal of Urology (16)
  3. Cancer (11)
  4. Urologic Oncology: Seminars and Original Investigations (5)
  5. European Urology (3)
  6. Seminars in Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Elsevier Science, Inc. (21)
  3. Wiley Blackwell (13)
  4. Elsevier Inc. (11)
  5. Lippincott Williams & Wilkins (4)
  6. Informa Healthcare (2)

More Publishers

Results (104)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
    Journal Article

    Dodd, P. M.; McCaffrey, J. A.; Mazumdar, M.; Scher, H.; Vlamis, V.; Higgins, G.; Herr, H.; Bajorin, D. F.
    Cancer (1999)

    Fulltext@MSK | Save
  • Anatomic site of primary transitional cell carcinoma (TCC) does not affect probability of response to M-VAC or survival
    Meeting Abstract

    McCaffrey, J. A.; Dodd, P. M.; Herr, H.; Vlamis, V.; Mazumdar, M.; Higgins, G.; Scher, H. I.; Bajorin, D. F.
    Journal of Urology (1998)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: Ten-year outcome
    Journal Article

    Herr, H. W.; Bajorin, D. F.; Scher, H. I.
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • NCCN urothelial cancer practice guidelines
    Journal Article

    Scher, H.; Bahnson, R.; Cohen, S.; Eisenberger, M.; Herr, H.; Kozlowski, J.; Lange, P.; Montie, J.; Pollack, A.; Raghaven, D.; more...
    Oncology (Norwalk) (1998)

    Fulltext@MSK | Save
  • Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial
    Journal Article

    Bajorin, D. F.; McCaffrey, J. A.; Hilton, S.; Mazumdar, M.; Kelly, W. K.; Scher, H. I.; Spicer, J.; Herr, H.; Higgins, G.
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • AJCC cancer staging handbook. 5th ed
    Book Whole

    American Joint Committee on Cancer
    Lippincott-Raven (1997)

    Fulltext@MSK | Save
  • Surgery for a post-chemotherapy residual mass in seminoma
    Journal Article

    Herr, H. W.; Sheinfeld, J.; Puc, H. S.; Heelan, R.; Bajorin, D. F.; Mencel, P.; Bosl, G. J.; Motzer, R. J.
    Journal of Urology (1997)

    Fulltext@MSK | Save
  • Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer
    Journal Article

    Donat, S. M.; Herr, H. W.; Bajorin, D. F.; Fair, W. R.; Sogani, P. C.; Russo, P.; Sheinfeld, J.; Scher, H. I.
    Journal of Urology (1996)

    Fulltext@MSK | Save
  • Defining new standards for adjuvant therapy of testis cancer: A reply - To the Editor
    Journal Article

    Motzer, R. J.; Sheinfeld, J.; Herr, H.
    Journal of Clinical Oncology (1996)

    Fulltext@MSK | Save
  • Optimal management of residual mass after chemotherapy in advanced seminoma: There is time for everything - In reply
    Journal Article

    Motzer, R. J.; Herr, H.
    Journal of Clinical Oncology (1996)

    Fulltext@MSK | Save